NASDAQ:SMMT | Profit Breakdown | Summit Therapeutics Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-01-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$215.7M
2026-03-31-$189.42M
2025-12-31-$219.17M
2025-09-30-$231.79M
2025-06-30-$565.71M
2025-03-31-$62.91M
2024-12-31$0.00-$65.61M-$61.2M
2024-09-30$0.00-$58.38M-$56.25M
2024-06-30-$59.62M-$60.39M
2024-03-31-$42.39M-$43.47M
2023-12-31$0.00-$36.21M-$36.57M
2023-09-30$0.00-$20.49M-$21.27M
2023-06-30$0.00-$15.79M-$14.72M
2023-03-31$0.00-$537.15M-$542.38M
2022-12-31$0.00-$20.3M-$19.23M
2022-09-30$220,000.00-$16.94M-$21.39M
2022-06-30$235,000.00-$12.69M-$16.77M
2022-03-31$250,000.00-$22.16M-$21.4M
2021-12-31$251,000.00-$26.05M-$27.1M-$27.1M
2021-09-30$1.31M-$19.49M-$19.6M-$19.6M
2021-06-30$57,000.00-$23.73M-$24.42M-$24.42M
2021-03-31$192,000.00-$16.92M-$17.49M-$17.49M
2020-12-31$185,000.00-$11.56M-$13.56M-$13.54M
2020-09-30$181,000.00-$16.94M-$17.8M-$17.74M
2020-06-30$170,000.00-$15.36M-$15.47M-$15.28M
2020-03-31$324,000.00-$9.34M-$6.08M-$6.13M
2019-09-30$148,000.00-$6.19M-$6.27M-$6.38M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$1.08B-$1.08B
2024-12-31$0.00-$226M-$221.32M-$221.32M
2023-12-31$0.00-$609.65M-$614.93M-$614.93M
2022-12-31$705,000.00-$72.09M-$78.78M-$78.78M
2021-12-31$1.81M-$86.19M-$88.6M-$88.6M
2020-12-31$860,000.00-$53.19M-$52.91M-$52.7M
2019-12-31$743,000.00-$27.47M-$29.09M-$29.13M
2019-01-31$57.09M$5.39M$9.08M$10.87M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.